{"name":"Antaros Medical","slug":"antaros-medical","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPNndrcGpnMGNrQVBKam9NQzdkX01qTVllblowZHRWOFgtNFAteVZuejVKZWcyT1RNcVBXLU9SY0VLSDBBSE1mUi1XRHFoM2o0eENVc3RTLVdlZ3BwN05hRUJpR0M0d2RkeEpEZ2tjcmZQZTRZUm5zWWRXOUFqTFhmRkZCQW93NDZpcm5yaDkxMUZDN29RbzJSMjNuZE0zU3hkblhCVmg4czBzZUNuZmhoZkdR?oc=5","date":"2026-03-04","type":"pipeline","source":"AstraZeneca","summary":"Sustainability approach to emerging companies - AstraZeneca","headline":"Sustainability approach to emerging companies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_gFBVV95cUxQaVVMZk9na0pNdFZvYzV6Y0NlRW9Sb2lWTS1LR0VPc25mMXEzU1duRnc5ZmFEbjl3c3FpSEczR2c3RGJfQTdMZzdkbVpIM2lXWFgyd2Z2S2VEaXF6ci1MVG9pc3hQRjRqZk9ES3RqRFZ0M3ZqRFotOXk4QjZ1NHBrOG1PWXZITU1Jakh0Z1JTWVFSX2g1dkVnbHlXdGtZS0xWSTFpWlBfLUJ6dlhPeGdWYi1jdHlXUFNHY2UwUGIzdUIwYndidWNLUGhjZDFUTGtzcng3REhva21RY01JOE95QVJwYTZmbnlCNHpKVlBzeDgtODBMNV9sNTAxdGZHQQ?oc=5","date":"2025-10-23","type":"pipeline","source":"PR Newswire UK","summary":"ANTARES VISION GROUP TO SHOWCASE FULL-STACK TRACEABILITY SOLUTIONS AT THE 40th GS1 HEALTHCARE GLOBAL CONFERENCE - PR Newswire UK","headline":"ANTARES VISION GROUP TO SHOWCASE FULL-STACK TRACEABILITY SOLUTIONS AT THE 40th GS1 HEALTHCARE GLOBAL CONFERENCE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNdUlma2d2MVhra1A3U29VWFN0X2xGYTdJZTBlZF9fcjA1OVduTl9DeVdhbWVFNEFLMVozRTE0ZEJDelR4S2Jmd2podG1VdU9Bb0NyMkwwQXVJTHBCTVYtV3ZORWtkRTVPaUVHb1FyUVpiZGoxblZfdFI4b05tN2JJRWlXQ2sxR1ppVE1TLXFNVUxDdy1sMHBQaERpcWwyeGZaY0dFdGtOd1U0elo5N2R4b1hsUTRTSEhqWkVyNjZkMm9OUG9DVVhZeGhvVm0yeEtPZjdRSGhQbk0tSFJDT1hac3c5UVJxNlFmdWx2NDlxcTJnMUpfOVBoelRvSGp1cWJMTGtJ?oc=5","date":"2025-09-26","type":"deal","source":"prnewswire.com","summary":"GUINEA-BISSAU AND ANTARES VISION GROUP EXPAND COLLABORATION TO ADVANCE PHARMACEUTICAL TRACEABILITY AND DIGITAL HEALTH - prnewswire.com","headline":"GUINEA-BISSAU AND ANTARES VISION GROUP EXPAND COLLABORATION TO ADVANCE PHARMACEUTICAL TRACEABILITY AND DIGITAL HEALTH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPNnVaRnNEWlY2eUZoRXNXODUwc0g4R1VlQ1RZdVNPQXhvc29ERWpfT2NRdXFXZEFHdVg3ZUhTeENqNzk0VS1HaEtmUWtReHFyV05EOENTUl9WUk54OTkwV0VDeW96N0xaOXhJdS0zRDVBb1RPaXJiWEJxNzI1YzUxRi01SlA4dXhQM0pxa3VjQ2RuOUFrR3ZCU2NJNDdnX2ZDV1kwQTI1clRTLWpSX2taTGNmQU9KTlcwSF9nQWpoTEptWWd5RHdyd2RzbktlNnZUQmJDclp2aXYtLXBaeU52RWZkZlI3SE1pUE00?oc=5","date":"2025-08-04","type":"pipeline","source":"Healthcare Packaging","summary":"Digital Solutions Improve Serialization and Cold Chain Management - Healthcare Packaging","headline":"Digital Solutions Improve Serialization and Cold Chain Management","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgJBVV95cUxPa2NIQ3N6S3EzX0NyS200bzhURi1KUnNEc01tRzR4MGNpQU1IdjBlZDQ3NWx2NmtlcXM0NWpYT3pfWHhlMGFqTFlxNzRYUGVYREo1MmI5NGlLUHNoUXk2MThpcllLSHRYZWgyY2dXTF9JNWplbmFXZXZjNGNCUGlDbmRwaThQWFQtd2cwRG5wV3h2eW9lX1hBYVVUUnBrWlZVNTVqd0ZnMzhCSE12MWZVdHZfTjdSQnN0cWtGdzJMbGhldWtZVHBJN2I2OHV5ck5mVVc0a2NxY1lnZmYtbVdUQ1NrVEtDeHd3U0tZUVhtWjdvZnFFLU9GVUZrOVU2VGZKQVozdnI4eEE1bFhxMzlQckhLRWVaV0QydUE?oc=5","date":"2025-06-10","type":"pipeline","source":"businesswire.com","summary":"Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serious Diseases - businesswire.com","headline":"Antares Therapeutics Launches with $177 Million to Develop First-in-Class Precision Medicines for Cancer and Other Serio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxOdlVkc0hTb1lSQlRNQmNsb0F6NTlmdW5IVG0taVZyM3BldnNXdl9tclRKVmlEaXYyMUJWQS1jdy11UDFxZDROX0ZCX0VkNVp5QjNFU3RaYnIxcVF1Zl90cVFkek5VMzd4YWltakxCSnNJRzBoUEhlWjlPa0xpZkJQMk9GMVpfYjBUd2Y5QTVwUFB5VVE?oc=5","date":"2024-09-25","type":"pipeline","source":"Yahoo Finance","summary":"Autoinjectors Market Global Forecast Report to 2035, Featuring Profiles of Antares Pharma, Elcam Medical, Oval Medical Technologies, PreciHealth, Recipharm, SHL Medical, Teva, Union Medico & More - Ya","headline":"Autoinjectors Market Global Forecast Report to 2035, Featuring Profiles of Antares Pharma, Elcam Medical, Oval Medical T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNX2xqWmxNSU5qVl9ROTlzdkFfT2pRSUZOaVN4blp6cWZjWUQ0VmtqQ1BGOWJFem5PQi1oMVN4YTI2bHBoTzhoVUxmNm5NYjB5LTJLZkxsX3d4a0h0VkFVQk85SUo5VGJUVnhDak9wR1VwanpUY19nNHFVNlZDSUh2d3NaVHBhUQ?oc=5","date":"2022-04-14","type":"deal","source":"Pharmaceutical Technology","summary":"Halozyme signs agreement to acquire Antares Pharma for $960m - Pharmaceutical Technology","headline":"Halozyme signs agreement to acquire Antares Pharma for $960m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisAFBVV95cUxPYVRpUFJwVFBYY09tV3UxQml4LVc5U0FTZ0kyN19PMzZ6ZWdrVFNZb1dZREY3SjNpX082a09ySDg2Sm9pN1BfSC15Ni1iNHJtTFJEMUp5UlRnU2FJTmw4NGpweHBuajc3dzdISm96YlVJQlhOb09BZVlhaE5Ic1M0eDBGM0pjV083enFjN29hMXBpNWVmMkw0MDA5UjV1MDRkX0F4N2tGVS1GOVNHSktLeQ?oc=5","date":"2022-04-13","type":"deal","source":"drugdeliverybusiness.com","summary":"Halozyme acquires Antares Pharma for $960M to create drug delivery company - drugdeliverybusiness.com","headline":"Halozyme acquires Antares Pharma for $960M to create drug delivery company","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxNeW9jd0hVekxBRzBISWZ0VEpSRERydVd0ZlJER2R1QkZYc2tWc2ZJZ1dWbnBIZVJIcS15T1BYbVdFSVZBcHVSTDFESTVka3VDYS1aTHM0OXdZSi1CZmRSSzVOMm8zUmctdzJKOVNMbmhGMEppZXZNRmVfLThibmZQSUk1ZDFHQmlYLXdkaFNCS3czSnBsZnhzVXlndUxSbjFTalQtSThRN182V1Q1eFJBT1BqUlpmb2VzQ1BYbHM3ZlV3UVRW?oc=5","date":"2022-02-07","type":"pipeline","source":"Fierce Pharma","summary":"Antares Pharma develops novel auto-injector devices for innovative combination products - Fierce Pharma","headline":"Antares Pharma develops novel auto-injector devices for innovative combination products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiY0FVX3lxTFBIVnlqaHZ0Q3Y3TlI1NW5jeDlMckViMWlaSlV5WUF3WFBqUWZTWk45bFNsWExZbEdNdDktcGZYUFdJVE16YTV3cGNJU09FSF9mc1pVdlNhNDQ1Zmg1b1VxMXdwdw?oc=5","date":"2021-09-27","type":"regulatory","source":"Wiley Online Library","summary":"Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with non-alcoholic fatty liver disease assessed by magnetic resonance imaging - Wiley ","headline":"Randomised clinical trial: semaglutide versus placebo reduced liver steatosis but not liver stiffness in subjects with n","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixwFBVV95cUxNWWYtZHJKd2hRSWwzZEVrZFFRUEU0dkdDcDhCdmxUbl9MY1NKVDZHS2dvclBQQlFvMTFYaHg1eENlaTYyT3J5TzNpVDdQaGZmblFJalFka0dkQ2xDSkFyQzczWExZWVBZbEJhbjNSeFRabjdGQWZiN0R0b0ZqSTQyNVpESUpGN0FDdTlWd1U1NWxLUjZCbnU0XzRnTmxic2tPUVRrT3BJSENka3FxZ2tjNU1ha0xCQ255VS1KeTFCOTB2T2tVU3Z3?oc=5","date":"2018-11-28","type":"patent","source":"Investing News Network","summary":"Antares’ Device Aids Teva’s Generic EpiPen Launch - Investing News Network","headline":"Antares’ Device Aids Teva’s Generic EpiPen Launch","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxNdkd1RlVtTFI0OFJCRERxMnVWQ0FBQVZ0N255VU1aNHk0cF9iaExDOHhGUkt0cnRHUG84UUU3VEdnc2wzM29jU0p6bE9JalI0VFVMd3ZnR1pULUFlc1k3dVQwOFNYZVl0ZHNvWEtkUl84SE4xMDRQS3hSUVRSWkFoWEV1eERUaDJ4aXpNNUFFaWtLdEh1NXRIc2xjeG52UmJqNjZ5b2t4MA?oc=5","date":"2017-01-15","type":"pipeline","source":"Drug Target Review","summary":"How imaging biomarkers are transforming drug development - Drug Target Review","headline":"How imaging biomarkers are transforming drug development","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}